Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

The new method improves alopecia areata lesion detection, aiding diagnosis and treatment.

The study identified key immune cell differences between mild and severe alopecia areata.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Antibodies help identify glycoproteins in normal skin and tumor cells.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Belimumab may cause hair loss in lupus patients.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.